AVTR - Avantor® to Participate in the 41st Annual J.P. Morgan Healthcare Conference

PR Newswire

RADNOR, Pa. , Jan. 3, 2023 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced that Michael Stubblefield , President and CEO, will present at the 41 ^st Annual J.P. Morgan Healthcare Conference on Monday, January 9 , at approximately 12:45 p.m. Eastern Standard Time .

To hear a live audio webcast of the presentation, visit the " Events & Presentations " page of Avantor's website, www.avantorsciences.com , under the "Investors" section. A replay of the webcast will be available for 30 days.

Avantor ^® , a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 225,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. For more information, visit avantorsciences.com and find us on LinkedIn , Twitter and Facebook .

Investor Relations Contact
Christina Jones
Vice President, Investor Relations
Avantor
805-617-5297
Christina.Jones@avantorsciences.com

Global Media Contact
Petro Kacur
Director, PR and External Communications
Avantor
404-408-0663
Petro.Kacur@avantorsciences.com

SOURCE Avantor and Financial News